NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Adagene Inc (NASDAQ: ADAG)

 
ADAG Technical Analysis
5
As on 9th Jun 2023 ADAG STOCK Price closed @ 1.25 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.42 & Strong Sell for SHORT-TERM with Stoploss of 7.18 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ADAGSTOCK Price

Open 1.35 Change Price %
High 1.39 1 Day -0.10 -7.41
Low 1.20 1 Week -0.07 -5.30
Close 1.25 1 Month -0.04 -3.10
Volume 40789 1 Year -6.26 -83.36
52 Week High 8.79 | 52 Week Low 0.90
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
ADAG
Daily Charts
ADAG
Intraday Charts
Whats New @
Bazaartrend
ADAG
Free Analysis
 
ADAG Important Levels Intraday
RESISTANCE1.62
RESISTANCE1.50
RESISTANCE1.43
RESISTANCE1.35
SUPPORT1.15
SUPPORT1.07
SUPPORT1.00
SUPPORT0.88
 
ADAG Forecast April 2024
4th UP Forecast8.07
3rd UP Forecast5.88
2nd UP Forecast4.53
1st UP Forecast3.18
1st DOWN Forecast-0.68
2nd DOWN Forecast-2.03
3rd DOWN Forecast-3.38
4th DOWN Forecast-5.57
 
ADAG Weekly Forecast
4th UP Forecast3.43
3rd UP Forecast2.73
2nd UP Forecast2.30
1st UP Forecast1.87
1st DOWN Forecast0.63
2nd DOWN Forecast0.20
3rd DOWN Forecast-0.23
4th DOWN Forecast-0.93
 
ADAG Forecast2024
4th UP Forecast17.34
3rd UP Forecast12.18
2nd UP Forecast8.99
1st UP Forecast5.8
1st DOWN Forecast-3.3
2nd DOWN Forecast-6.49
3rd DOWN Forecast-9.68
4th DOWN Forecast-14.84
 
 
ADAG Other Details
Segment EQ
Market Capital 496774368.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ADAG Address
ADAG
 
ADAG Latest News
 
Your Comments and Response on Adagene Inc
 
ADAG Business Profile
Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. Its lead product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase Ib clinical trials for the treatment advanced solid tumors and non-Hodgkin's lymphoma; ADG126, a fully-human anti-CTLA-4 mAb for cancer treatment; and ADG116, a human ligand-blocking anti-CTLA-4 mAb, which is in Phase I clinical trial for the treatment of various tumors. The company was founded in 2011 and is headquartered in Suzhou, China. Address: Building C14, Suzhou, China, 25125
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service